poisar

Stocks · News reference

JPMorgan Maintains Buy Rating on Vera Therapeutics

Fiscal.ai

JPMorgan analyst Anupam Rama has maintained a Buy rating on Vera Therapeutics with a price target of $75.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading